Citigroup
VERA icon

Citigroup’s Vera Therapeutics VERA Stock Holding History

Citigroup’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
266,758
+16,789
+7% +$626K ﹤0.01% 1505
2026
Q1 		$10.1M Buy
249,969
+75,714
+43% +$3.26M ﹤0.01% 1472
2025
Q4 		$8.82M Buy
174,255
+165,121
+1,808% +$5.86M ﹤0.01% 1634
2025
Q3 		$265K Sell
9,134
-69,403
-88% -$1.6M ﹤0.01% 3877
2025
Q2 		$1.85M Sell
78,537
-63,714
-45% -$1.43M ﹤0.01% 2715
2025
Q1 		$3.42M Buy
142,251
+24,767
+21% +$796K ﹤0.01% 2251
2024
Q4 		$4.97M Buy
117,484
+88,080
+300% +$3.9M ﹤0.01% 1965
2024
Q3 		$1.3M Buy
29,404
+8,122
+38% +$308K ﹤0.01% 3039
2024
Q2 		$770K Sell
21,282
-131,286
-86% -$5.21M ﹤0.01% 3087
2024
Q1 		$6.58M Buy
152,568
+82,263
+117% +$2.93M ﹤0.01% 1525
2023
Q4 		$1.08M Buy
70,305
+12,915
+23% +$164K ﹤0.01% 2759
2023
Q3 		$787K Buy
57,390
+47,322
+470% +$812K ﹤0.01% 2701
2023
Q2 		$162K Buy
+10,068
New +$90.9K ﹤0.01% 3997
2023
Q1 		– Sell
-467
Closed -$9.04K – 5884
2022
Q4 		$9.04K Sell
467
-783
-63% -$14.2K ﹤0.01% 4872
2022
Q3 		$27K Sell
1,250
-9,980
-89% -$187K ﹤0.01% 4633
2022
Q2 		$153K Buy
11,230
+335
+3% +$5.85K ﹤0.01% 3992
2022
Q1 		$256K Buy
10,895
+8,238
+310% +$177K ﹤0.01% 3928
2021
Q4 		$71K Buy
2,657
+1,847
+228% +$40.9K ﹤0.01% 4912
2021
Q3 		$14K Buy
+810
New +$14.5K ﹤0.01% 5383

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citigroup's VERA Position: Q2 2026 in Review

Citigroup increased its Vera Therapeutics (VERA) stake by 6.7% in Q2 2026, buying an estimated $626K and bringing the position to 266,758 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1505.

Citigroup first reported a position in VERA in Q3 2021 and has held it in 19 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Citigroup held 266,758 shares of Vera Therapeutics worth $11.4M as of Q2 2026.
  • Citigroup bought 16,789 Vera Therapeutics shares in Q2 2026, an estimated $626K.
  • Vera Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #1505 holding.
  • Citigroup first reported a position in Vera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.